A multicenter study of prognosis after the initiation of dialysis in patients with chronic kidney disease
Not Applicable
- Conditions
- Chronic kidney disease
- Registration Number
- JPRN-UMIN000007096
- Lead Sponsor
- agoya Daini Red Cross Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 1200
Inclusion Criteria
Not provided
Exclusion Criteria
All patients: 1) acute kidney injury, 2) death before discharge from hospital
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method All-cause mortality after initiation of dialysis
- Secondary Outcome Measures
Name Time Method 1) Cardiovascular events (admission due to heart failure, acute coronary syndrome, PCI, CABG, admission due to peripheral artery disease) 2) Admission due to infection
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What prognostic biomarkers are associated with mortality in CKD patients initiating dialysis per AICOPP study?
How do hemodialysis vs. peritoneal dialysis modalities compare in long-term outcomes for AICOPP cohort patients?
What molecular pathways correlate with adverse events post-dialysis initiation in chronic kidney disease populations?
Are there specific CKD subtypes with distinct survival trajectories identified in the AICOPP observational trial?
How does the AICOPP study inform combination therapies to mitigate dialysis-related complications in CKD patients?